[De...] Posted May 5, 2023 Share Posted May 5, 2023 Riluzole and Sorafenib in patients with advanced solid tumors: a Phase I trial https://scienmag.com/riluzole-and-sorafenib-in-patients-with-advanced-solid-tumors-a-phase-i-trial/ " Overexpression of metabotropic glutamate receptor 1 (GRM1) has been implicated in the pathogenesis of multiple cancers. Riluzole, an inhibitor of glutamate release, showed synergistic antitumor activity in combination with the multi-kinase inhibitor sorafenib in preclinical models." Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now